KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Neogenomics (NEO) Leases (2016 - 2025)

Historic Leases for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $78.4 million.

  • Neogenomics' Leases fell 143.12% to $78.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $78.4 million, marking a year-over-year decrease of 143.12%. This contributed to the annual value of $78.4 million for FY2025, which is 143.12% down from last year.
  • Neogenomics' Leases amounted to $78.4 million in Q4 2025, which was down 143.12% from $80.1 million recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Leases peaked at $102.3 million during Q3 2021, and registered a low of $50.9 million during Q1 2021.
  • Over the past 5 years, Neogenomics' median Leases value was $86.9 million (recorded in 2023), while the average stood at $86.1 million.
  • Its Leases has fluctuated over the past 5 years, first soared by 12320.58% in 2021, then crashed by 1327.9% in 2024.
  • Quarter analysis of 5 years shows Neogenomics' Leases stood at $102.2 million in 2021, then decreased by 5.96% to $96.1 million in 2022, then dropped by 4.52% to $91.8 million in 2023, then dropped by 13.28% to $79.6 million in 2024, then decreased by 1.43% to $78.4 million in 2025.
  • Its Leases was $78.4 million in Q4 2025, compared to $80.1 million in Q3 2025 and $82.9 million in Q2 2025.